Clinical Trial Update: Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating induction therapy with a PD-1 antibody in combination with platinum-based doublet chemotherapy for locally advanced non-smal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• PD-1 antibody (PD-1 inhibitor)
• Platinum-based doublet chemotherapy

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Locally Advanced, Non-small Cell Lung Cancer | Phase 2 | Status: RECRUITING